€ million |
|
Note |
|
2024 |
|
2025 |
|||
|---|---|---|---|---|---|---|---|---|---|
Income after income taxes |
|
|
|
(2,546) |
|
(3,595) |
|||
of which attributable to noncontrolling interest |
|
|
6 |
|
25 |
||||
of which attributable to Bayer AG stockholders |
|
|
|
(2,552) |
|
(3,620) |
|||
Remeasurements of the net defined benefit liability for post-employment benefit plans |
|
|
453 |
|
1,100 |
||||
Income taxes |
|
|
(83) |
|
(505) |
||||
Other comprehensive income from remeasurements of the net defined benefit liability for post-employment benefit plans |
|
|
|
370 |
|
595 |
|||
Changes in fair values of equity instruments measured at fair value |
|
|
|
(87) |
|
(29) |
|||
Income taxes |
|
|
12 |
|
3 |
||||
Other comprehensive income from equity instruments measured at fair value |
|
|
|
(75) |
|
(26) |
|||
Income taxes |
|
|
– |
|
(1) |
||||
Other comprehensive income relating to associates accounted for using the equity method |
|
|
|
– |
|
(1) |
|||
Other comprehensive income that will not be reclassified subsequently to profit or loss |
|
|
|
295 |
|
568 |
|||
Changes in fair values of derivatives designated as cash flow hedges |
|
|
(16) |
|
186 |
||||
Reclassified to profit or loss |
|
|
|
(85) |
|
(142) |
|||
Income taxes |
|
|
14 |
|
(24) |
||||
Other comprehensive income from cash flow hedges |
|
|
|
(87) |
|
20 |
|||
Changes in time value of options used as hedging instrument |
|
|
1 |
|
(1) |
||||
Other comprehensive income from time value of options |
|
|
|
1 |
|
(1) |
|||
Changes in exchange differences recognized on translation of operations outside the eurozone |
|
|
1,498 |
|
(2,858) |
||||
Reclassified to profit or loss |
|
|
(102) |
|
(71) |
||||
Other comprehensive income from exchange differences |
|
|
1,396 |
|
(2,929) |
||||
Other comprehensive income relating to associates accounted for using the equity method |
|
|
|
(8) |
|
23 |
|||
Other comprehensive income that may be reclassified subsequently to profit or loss |
|
|
|
1,302 |
|
(2,887) |
|||
Total other comprehensive income1 |
|
|
|
1,597 |
|
(2,319) |
|||
of which attributable to noncontrolling interest |
|
|
|
3 |
|
(27) |
|||
of which attributable to Bayer AG stockholders |
|
|
|
1,594 |
|
(2,292) |
|||
Total comprehensive income |
|
|
|
(949) |
|
(5,914) |
|||
of which attributable to noncontrolling interest |
|
|
|
9 |
|
(2) |
|||
of which attributable to Bayer AG stockholders |
|
|
|
(958) |
|
(5,912) |
|||
|
|||||||||